Dr. Banashree Bondhopadhyay | Oncology | Best Researcher Award

Amity University Uttar Pradesh, Noida | India

Dr. Banashree Bondhopadhyay is a distinguished biomedical researcher and Assistant Professor at Amity University, Noida, with a notable record of scientific productivity and impact in cancer biology and medical biotechnology. Her scholarly achievements include an h-index of 14, reflecting the consistent influence of her work across diverse biomedical domains, and a total citation count of 627 (overall) with 314 citations since 2020, according to her Google Scholar profile. She has contributed to over 80 peer-reviewed documents, encompassing high-impact journal papers, book chapters, and conference proceedings. Her research primarily focuses on molecular oncology, translational immunology, and nanotherapeutics, emphasizing pathways such as PI3K and OBSCN in breast cancer progression. Dr. Bondhopadhyay’s collaborative publications in prestigious journals including Cancers, Scientific Reports, and Tumor Biology underscore her global research engagement. In addition to publications, she has received several honors, including the Shri K.N. Narasimhiah Young Scientist Award (2025) and multiple Best Oral Presentation Awards. She is also a reviewer for international journals and an active member of several scientific societies. Her innovative approach combining molecular biology with computational modeling continues to contribute significantly to precision oncology and next-generation therapeutic design.

Featured Publications

Bondhopadhyay, B., Aggarwal, N., Chourasia, M., Sisodiya, S., & Hussain, S. (2025). Levonorgestrel-induced modulation of triple negative breast cancer proliferation via glucocorticoid receptor. 3 Biotech.

Gupta, S., Haque, Y., & Bondhopadhyay, B. (2025). Role of reactive oxygen species in cellular signalling: Insights into pathological processes and therapeutic strategies. In The Role of Reactive Oxygen Species in Human Health and Disease

Bondhopadhyay, B., Urs, T. J., Gupta, S., & Ruchika. (2025). Nano-engineered therapies for breast cancer: A new paradigm to overcome multidrug resistance. In Innovations and Applications of Advanced Biomaterials in Healthcare and Engineering

Banashree Bondhopadhyay | Oncology | Best Researcher Award

You May Also Like